NovaBridge Biosciences NBP
NASDAQ NBP
$1.38 +0.01 (+1.09%)
As of: Sep 30, 2026 · 11:33 AM EDT

NovaBridge Biosciences (NBP) Total Debt (2018 - 2023)

Updated

NovaBridge Biosciences (NBP) posted Total Debt of $4.16 million for Q4 2023, up 56.2% from $2.67 million a year earlier.

Analysis

NovaBridge Biosciences (NBP) Total Debt (2018 - 2023) Analysis & Trends

At the end of FY2023, NovaBridge Biosciences' Total Debt came in at $4.24 million, up 50.2% from FY2022.

  • Annual Total Debt shows a five-year compound annual growth rate of -18.9% (FY2018 to FY2023).
  • In prior years, NovaBridge Biosciences' Total Debt was $2.82 million in FY2022 and $7.18 million in FY2019 (-40.7%).
  • Quarterly Total Debt has run from a low of $2.67 million in Q4 2022 to a high of $7.09 million in Q4 2019 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 NovaBridge Biosciences 149.78 Mn 149.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 4.16 Mn
Jun 30, 2023 4.28 Mn
Dec 31, 2022 2.67 Mn
Dec 31, 2019 7.09 Mn
Dec 31, 2018 11.57 Mn
API Access

NovaBridge Biosciences Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=NBP&period=max&api_key=YOUR_API_KEY